Teva receives FDA approval for filgrastim in the US
FDA approves Teva's biosimilar for neutropaenia in cancer patients - PMLiVE
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo- filgrastim, short-acting recombinant human granulocyte colony-stimulating factors | Request PDF
Tbo-filgrastim Approved for Chemotherapy-Induced Neutropenia - MPR
New Granix Syringes Approved for Self-Administration - MPR
Biosimilar strategy for drugs treating neutropenia using MedDrive™ - Prime Therapeutics LLC
Filgrastim -Teva®
Tevagrastim 300 µg / 0,5 mL - Laboratorio Chile | Teva
GRANIX® (tbo-filgrastim) injection
These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012
Japan approves second biosimilar G-CSF
Filgrastim-Teva 48 Mio E/0.8ml 5 Fertspr 0.8 ml auf Rezept kaufen | Amavita
Final Appraisal Report Filgrastim (TevaGrastim®▽) Teva UK Limited Advice No: 1410 – August 2010 Recommendation of AWMSG
Filgrastim-Teva Inj Lös 30 Mio E/0.5ml Fertspr 0.5 ml auf Rezept kaufen | Amavita
SWICA - FILGRASTIM Teva 48 Mio E/0.8ml
BUY Tbo-Filgrastim (Granix) 300 ug/.5mL from GNH India at the best price available.
Delays in FDA approval of biosimilar G-CSF (filgrastim)
Granix: Package Insert / Prescribing Information - Drugs.com
Teva bolsters its biosimilar business through $160m Celltrion deal
SWICA - FILGRASTIM Teva 30 Mio E/0.5ml
Granix® Hematopoietic Agent TBO-Filgrastim, Preservative Free 480 mcg / 0.8 mL Subcutaneous Injection Prefilled Syringe 5 Syringes - Suprememed
Filgrastim -Teva®
Resources & Support from Teva CORE | GRANIX
